PCBL Chemical Ltd, part of the RP-Sanjiv Goenka Group, has steadily expanded its footprint from a traditional carbon black manufacturer to a diversified specialty chemicals company. As India's largest carbon black producer, the company today serves clients across automotive, industrial, and consumer sectors — and is now making a deliberate push into higher-margin specialty chemicals.
Business Overview
Carbon black remains PCBL's core business — a critical raw material used in tyres, plastics, inks, and coatings. Over the years, the company has expanded its specialty black portfolio to cater to segments such as electric vehicles (EVs), plastics, and coatings. Its Industry 4.0-enabled manufacturing plants support operational efficiency, with utilisation rates exceeding 85% at newer facilities.
The company currently has an installed carbon black capacity of 7,90,000 MT and is on track to cross 10 lakh MT by FY28/FY29 through brownfield and greenfield expansions across Tamil Nadu, Andhra Pradesh, and Mundra.
The Aquapharm Acquisition
In 2024, PCBL acquired Aquapharm Chemicals, a global player in water treatment and oil & gas chemicals. The acquisition marked a significant step in PCBL's specialty chemicals strategy — bringing in a new global customer base and diversifying its revenue mix beyond carbon black.
Financial Performance
PCBL's three-year revenue CAGR stands at approximately 15%, with a cumulative stock return of 138% since 2022. However, FY25 has been a softer year — TTM earnings declined 42% and sales growth came in at -0.4%. Despite near-term pressure, management has outlined a target of ₹16,000 crore in revenue and 5x PAT growth by 2030.
Sustainability & Green Initiatives
PCBL has 122 MW of captive green power installed, targeting 134 MW by FY27. It has also launched ecozen — a circular carbon black from recycled materials — and holds an EcoVadis Gold rating.
Growth Drivers
Three themes underpin PCBL's medium-to-long-term outlook — EV and specialty black demand, water treatment and oil & gas chemicals via Aquapharm, and expansion into international markets including the Middle East and USA.
Key Risks
Debt-to-equity stands at 1.36x. Earnings remain sensitive to commodity cycles, and timely execution of capacity ramp-ups and Aquapharm integration will be key monitorables.
Conclusion
PCBL Chemical Ltd presents a case of a commodity manufacturer in transition — expanding into specialty chemicals through organic capacity additions and strategic acquisitions. Near-term financial performance has been under pressure, but the longer-term structural direction appears clearly defined.
Prepared by: Tanisha Mulewa
This content is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Readers are advised to conduct their own due diligence before making any investment decisions.
Investments in securities market are subject to market risks, read all the related documents carefully before investing. Bonanza Portfolio Limited, SEBI Registration No: INZ000212137, RA ID - INH100001666 www.bigul.co